Targeting the Jak/Signal Transducer and Activator of Transcription 3 Pathway with Ruxolitinib in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa–Squamous Cell Carcinoma

Autor: Jacków, Joanna 1, 2, Rami, Avina 1, Hayashi, Ryota 1, Hansen, Corey 1, Guo, Zongyou 1, DeLorenzo, Dominick 1, Pappalardo, Alberto 1, Alvarez Cespedes, David 1, Kim, Arianna L. 1, Perez-Lorenzo, Rolando 1, Owens, David M. 1, Christiano, Angela M. 1, 3, ∗
Zdroj: In Journal of Investigative Dermatology April 2021 141(4):942-946
Databáze: ScienceDirect